What question did this study set out to answer?

This study aims to analyze the impact of socioeconomic and hospital-level factors on inpatient mortality in patients with plasma cell dyscrasias.

December 8, 2025BloodOpen Access

Socioeconomic, racial, and hospital-level disparities in inpatient mortality among patients with plasma cell dyscrasias: A 2016-2022 nationwide analysis from the national inpatient sample

View Full Paper

Ask AI

Bookmark

Authors

Retrospective analysis highlights racial and socioeconomic disparities affecting inpatient mortality in plasma cell dyscrasias.

This study aims to analyze the impact of socioeconomic and hospital-level factors on inpatient mortality in patients with plasma cell dyscrasias.
Conducted a retrospective analysis using the National Inpatient Sample from 2016 to 2022.
Included adults with plasma cell dyscrasias identified by ICD-10 codes.
Assessed socioeconomic status using ZIP-code–linked income quartiles and Charlson Comorbidity Index.
Utilized a multivariable survey-weighted logistic regression model to estimate adjusted odds ratios.
Excluded patients with missing data on key variables.
Analyzed data from 195,384 patients with an overall mean age of 68 years.
Found that patients with Medicaid or lacking insurance had higher odds of mortality compared to those with Medicare.
Identified higher mortality odds linked to plasma cell leukemia and relapse of multiple myeloma.
Noted that treatment at larger hospitals associated with higher mortality rates compared to smaller hospitals.

Flowers et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Retrospective analysis highlights racial and socioeconomic disparities affecting inpatient mortality in plasma cell dyscrasias.

This study aims to analyze the impact of socioeconomic and hospital-level factors on inpatient mortality in patients with plasma cell dyscrasias.
Conducted a retrospective analysis using the National Inpatient Sample from 2016 to 2022.
Included adults with plasma cell dyscrasias identified by ICD-10 codes.
Assessed socioeconomic status using ZIP-code–linked income quartiles and Charlson Comorbidity Index.
Utilized a multivariable survey-weighted logistic regression model to estimate adjusted odds ratios.
Excluded patients with missing data on key variables.
Analyzed data from 195,384 patients with an overall mean age of 68 years.
Found that patients with Medicaid or lacking insurance had higher odds of mortality compared to those with Medicare.
Identified higher mortality odds linked to plasma cell leukemia and relapse of multiple myeloma.
Noted that treatment at larger hospitals associated with higher mortality rates compared to smaller hospitals.

Flowers et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark